Guar gum-based colon-specific drug delivery systems for the treatment of Inflammatory Bowel Diseases

2009 ◽  
Vol 15 ◽  
pp. S56
Author(s):  
S Yellela ◽  
S S ◽  
R YV
2020 ◽  
Vol 21 (18) ◽  
pp. 6502
Author(s):  
Adrian H. Teruel ◽  
Isabel Gonzalez-Alvarez ◽  
Marival Bermejo ◽  
Virginia Merino ◽  
Maria Dolores Marcos ◽  
...  

Colonic Drug Delivery Systems (CDDS) are especially advantageous for local treatment of inflammatory bowel diseases (IBD). Site-targeted drug release allows to obtain a high drug concentration in injured tissues and less systemic adverse effects, as consequence of less/null drug absorption in small intestine. This review focused on the reported contributions in the last four years to improve the effectiveness of treatments of inflammatory bowel diseases. The work concludes that there has been an increase in the development of CDDS in which pH, specific enzymes, reactive oxygen species (ROS), or a combination of all of these triggers the release. These delivery systems demonstrated a therapeutic improvement with fewer adverse effects. Future perspectives to the treatment of this disease include the elucidation of molecular basis of IBD diseases in order to design more specific treatments, and the performance of more in vivo assays to validate the specificity and stability of the obtained systems.


2012 ◽  
Vol 9 (4) ◽  
pp. 311-318 ◽  
Author(s):  
Akanksha Tiwari ◽  
Raj Kumar Shukla ◽  
Suresh Tiwari ◽  
Surti Naazneen

Author(s):  
Suryakanta Swain ◽  
Sitty Manohar Babu ◽  
Chinam Niranjan Patra ◽  
Muddana Eswara Rao

Sign in / Sign up

Export Citation Format

Share Document